Relationship Between Androgen Deprivation Therapy for Prostate Cancer and Risk of SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis

被引:3
作者
Kim, Do Kyung [1 ]
Park, Jae Joon [1 ]
Yang, Won Jae [1 ]
Doo, Seung Whan [1 ]
Kim, Jae Heon [1 ,2 ]
机构
[1] Soonchunhyang Univ, Seoul Hosp, Dept Urol, Coll Med, 59 Daesagwan Ro, Seoul 140743, South Korea
[2] Soonchunhyang Univ, Urol Biomed Res Inst, Seoul Hosp, Seoul, South Korea
关键词
Prostate Cancer; Androgen Deprivation Therapy; COVID-19; SARS Virus; TESTOSTERONE; ESTROGENS; COVID-19;
D O I
10.3346/jkms.2022.37.e237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several cohort studies have explored the relationship between androgen deprivation therapy (ADT) and the severity of coronavirus disease 2019 (COVID-19). This study aimed to characterize the relationship between ADT and the severity of COVID-19 in patients with prostate cancer. Methods: A systematic search was conducted using PubMed, Embase, and Cochrane Library databases from the inception of each database until February 31, 2020. Patients with prostate cancer who were treated with ADT were assigned to treatment group while those patients who were not treated with ADT were assigned to the control group. Outcomes were severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) positivity, hospitalization, intensive care unit (ICU) admission, and death. The risk of bias was evaluated using ROBINS-I (Risk Of Bias In Non-randomized Studies of Interventions) tool. Results: Three studies with qualitative synthesis were included. Finally, two studies with quantitative synthesis having a total of 44,213 patients were included for the present systematic review. There was no significant difference in SARS-CoV-2 positive rate (odds ratio [OR], 0.52; 95% confidence intervals [Cis], 0.13-2.09; P = 0.362), hospitalization (OR, 0.52; 95% CIs, 0.07-3.69; P = 0.514), ICU admission (OR, 0.93; 95% CIs, 0.39-2.23, P = 0.881), or death (OR, 0.88; 95% CIs, 0.06-12.06; P = 0.934) between ADT and non-ADT groups. Conclusion: Qualitative and quantitative analyses of previous studies revealed no significant effect of ADT on COVID-19. However, more studies with higher quality that explore biochemical and immunological factors involved are needed to confirm this finding in the future.
引用
收藏
页数:11
相关论文
共 24 条
  • [1] Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19)
    Al-Lami, Rasha A.
    Urban, Randall J.
    Volpi, Elena
    Algburi, Ammar M. A.
    Baillargeon, Jacques
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (08) : 1710 - 1714
  • [2] Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
    Bennani, N. N.
    Bennani-Baiti, I. M.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (11) : 1585 - 1586
  • [3] Angiotensin-converting enzyme 2 (ACE2),SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)
    Bourgonje, Arno R.
    Abdulle, Amaal E.
    Timens, Wim
    Hillebrands, Jan-Luuk
    Navis, Gerjan J.
    Gordijn, Sanne J.
    Bolling, Marieke C.
    Dijkstra, Gerard
    Voors, Adriaan A.
    Osterhaus, Albert D. M. E.
    van Der Voort, Peter H. J.
    Mulder, Douwe J.
    van Goor, Harry
    [J]. JOURNAL OF PATHOLOGY, 2020, 251 (03) : 228 - 248
  • [4] Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?
    George M. Bwire
    [J]. SN Comprehensive Clinical Medicine, 2020, 2 (7) : 874 - 876
  • [5] On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2
    Caffo, O.
    Zagonel, V.
    Baldessari, C.
    Berruti, A.
    Bortolus, R.
    Buti, S.
    Ceresoli, G. L.
    Donini, M.
    Ermacora, P.
    Fornarini, G.
    Fratino, L.
    Masini, C.
    Massari, F.
    Mosca, A.
    Mucciarini, C.
    Procopio, G.
    Tucci, M.
    Verri, E.
    Zucali, P.
    Buttigliero, C.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (10) : 1415 - 1416
  • [6] Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
    Channappanavar, Rudragouda
    Fett, Craig
    Mack, Matthias
    Ten Eyck, Patrick P.
    Meyerholz, David K.
    Perlman, Stanley
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (10) : 4046 - 4053
  • [7] Third Trimester Estrogens and Maternal Breast Cancer: Prospective Evidence
    Cohn, Barbara A.
    Cirillo, Piera M.
    Hopper, Bill R.
    Siiteri, Pentti K.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (10) : 3739 - 3748
  • [8] Cutolo M, 2020, CLIN EXP RHEUMATOL, V38, P383, DOI 10.55563/clinexprheumatol/qb05rr
  • [9] GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
    Guyatt, Gordon
    Oxman, Andrew D.
    Akl, Elie A.
    Kunz, Regina
    Vist, Gunn
    Brozek, Jan
    Norris, Susan
    Falck-Ytter, Yngve
    Glasziou, Paul
    deBeer, Hans
    Jaeschke, Roman
    Rind, David
    Meerpohl, Joerg
    Dahm, Philipp
    Schuenemann, Holger J.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) : 383 - 394
  • [10] Longitudinal effects of aging on serum total and free testosterone levels in healthy men
    Harman, SM
    Metter, EJ
    Tobin, JD
    Pearson, J
    Blackman, MR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) : 724 - 731